Entity
Description
  • Value proposition

    SCINTIX biology-guided radiotherapy is now FDA cleared.

    SCINTIX biology-guided radiotherapy now FDA cleared.

    SCINTIX® therapy detects and responds to signals emitted from the cancer itself and, for the first time, uses them to deliver immediate treatment for tumors in the lung or bone that may arise from primary or metastatic disease.

    cancer care, radiation therapy, life sciences, medical devices, biotechnology, oncology, manufacturing, PET scanner, electrical engineering, product engineering, algorithms engineer, new product development, and software engineering

  • Home Page - RefleXion

    SCINTIX® technology is a novel therapy for patients with tumors in the lung or bone arising from primary and metastatic cancer. This breakthrough technology uses live, continuously updated data throughout the entire treatment session to determine where to deliver radiotherapy.

  • https://reflexion.com/
Corporate interactions BETA
Corporate TypeTweets Articles
NYSE
NYSE
Finance, Financial Services
NYSE
Finance, Financial Services
Other

14 Feb 2024


Sofinnova Partners
Sofinnova Partners
Financial Services
Sofinnova Partners
Financial Services
Capitalistic
Partnership
Not event

4 Apr 2023


Similar entities
Loading...
Loading...
Social network dynamics